KR900002840B1 - 안정화된 효소 결합체 조성물 - Google Patents

안정화된 효소 결합체 조성물 Download PDF

Info

Publication number
KR900002840B1
KR900002840B1 KR1019850000659A KR850000659A KR900002840B1 KR 900002840 B1 KR900002840 B1 KR 900002840B1 KR 1019850000659 A KR1019850000659 A KR 1019850000659A KR 850000659 A KR850000659 A KR 850000659A KR 900002840 B1 KR900002840 B1 KR 900002840B1
Authority
KR
South Korea
Prior art keywords
composition
polyethylene glycol
enzyme
enzyme conjugate
calcium salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
KR1019850000659A
Other languages
English (en)
Korean (ko)
Other versions
KR860006542A (ko
Inventor
안토니 아노이스 마크
엘머 린드버그 로저
Original Assignee
에보트 레보러터리즈
조세프 엠.버닠
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 에보트 레보러터리즈, 조세프 엠.버닠 filed Critical 에보트 레보러터리즈
Publication of KR860006542A publication Critical patent/KR860006542A/ko
Application granted granted Critical
Publication of KR900002840B1 publication Critical patent/KR900002840B1/ko
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/18Multi-enzyme systems
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531Production of immunochemical test materials
    • G01N33/532Production of labelled immunochemicals
    • G01N33/535Production of labelled immunochemicals with enzyme label or co-enzymes, co-factors, enzyme inhibitors or enzyme substrates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Saccharide Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Detergent Compositions (AREA)
  • Medicinal Preparation (AREA)
KR1019850000659A 1984-02-03 1985-02-02 안정화된 효소 결합체 조성물 Expired KR900002840B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57682484A 1984-02-03 1984-02-03
US576824 1984-02-03

Publications (2)

Publication Number Publication Date
KR860006542A KR860006542A (ko) 1986-09-13
KR900002840B1 true KR900002840B1 (ko) 1990-05-01

Family

ID=24306158

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019850000659A Expired KR900002840B1 (ko) 1984-02-03 1985-02-02 안정화된 효소 결합체 조성물

Country Status (14)

Country Link
EP (1) EP0152847B1 (enExample)
JP (1) JPH06104064B2 (enExample)
KR (1) KR900002840B1 (enExample)
AT (1) ATE38097T1 (enExample)
AU (1) AU578065B2 (enExample)
CA (1) CA1249782A (enExample)
DE (1) DE3565722D1 (enExample)
DK (1) DK44185A (enExample)
ES (1) ES8609728A1 (enExample)
GR (1) GR850292B (enExample)
IE (1) IE57714B1 (enExample)
IL (1) IL74177A (enExample)
NZ (1) NZ210990A (enExample)
ZA (1) ZA85705B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5206344A (en) * 1985-06-26 1993-04-27 Cetus Oncology Corporation Interleukin-2 muteins and polymer conjugation thereof
US4766106A (en) * 1985-06-26 1988-08-23 Cetus Corporation Solubilization of proteins for pharmaceutical compositions using polymer conjugation
US4810638A (en) * 1986-07-24 1989-03-07 Miles Inc. Enzyme-labeled antibody reagent with polyalkyleneglycol linking group
IE64284B1 (en) * 1987-08-03 1995-07-26 Ddi Pharmaceuticals Conjugates of superoxide dismutase
DE3726634A1 (de) * 1987-08-11 1989-02-23 Biotest Ag Stabilisiertes peroxidasepraeparat
FR2626373B1 (fr) * 1988-01-22 1993-10-15 Stabiligen Procede de preparation d'un traceur stable et traceur obtenu
DE3901458A1 (de) 1989-01-19 1990-07-26 Behringwerke Ag Verwendung von zwei- oder dreiwertigen kationen in immunchemischen tests
DK131792D0 (enExample) * 1992-10-28 1992-10-28 Novo Nordisk As
HK1043801A1 (zh) 1998-08-28 2002-09-27 格莱风科学公司 精确长度的聚酰胺链、其制备方法和其与蛋白质的缀合物
JP2005526492A (ja) * 2001-12-21 2005-09-08 マキシゲン・エイピーエス アディポネクチンフラグメントおよび結合体

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3065827D1 (en) * 1979-08-23 1984-01-12 Ivan Endre Modrovich Method of stabilizing an enzyme solution for use in total cholesterol determination, stabilized solution and test kit therefor
GB2057572B (en) * 1979-08-30 1984-03-07 White W T Device for metering fluid flow
GB2067572A (en) * 1980-01-21 1981-07-30 Abbott Lab Partially oxidized enzyme conjugates
FR2537991A1 (fr) * 1982-12-20 1984-06-22 Sanders Procede pour stabiliser des enzymes liquides, enzymes liquides ainsi stabilisees et aliment renfermant de telles enzymes notamment pour des animaux monogastriques

Also Published As

Publication number Publication date
IE57714B1 (en) 1993-03-10
AU3829185A (en) 1985-08-08
IL74177A (en) 1989-09-10
AU578065B2 (en) 1988-10-13
EP0152847B1 (en) 1988-10-19
ES8609728A1 (es) 1986-09-01
KR860006542A (ko) 1986-09-13
EP0152847A1 (en) 1985-08-28
JPH06104064B2 (ja) 1994-12-21
GR850292B (enExample) 1985-06-05
IL74177A0 (en) 1985-04-30
CA1249782A (en) 1989-02-07
DK44185A (da) 1985-08-04
ZA85705B (en) 1985-09-25
NZ210990A (en) 1988-02-29
ATE38097T1 (de) 1988-11-15
DE3565722D1 (en) 1988-11-24
ES540059A0 (es) 1986-09-01
DK44185D0 (da) 1985-01-31
IE850250L (en) 1985-08-03
JPS60184385A (ja) 1985-09-19

Similar Documents

Publication Publication Date Title
KR880001533B1 (ko) 항원 항체반응의 측정방법 및 그 시약
US5094956A (en) Fecal sample immunoassay composition and method
US3485587A (en) Protein indicator
US4615972A (en) Stabilization of indicators for detecting enzyme activity
JPH0684970B2 (ja) 糞便中の潜血検出方法
KR900002840B1 (ko) 안정화된 효소 결합체 조성물
US3533749A (en) Method for the determination of total albumin
CN110907641A (zh) 一种透明质酸检测试剂盒及检测方法
US4782023A (en) Stabilized horseradish peroxidase conjugate composition
JPH06300761A (ja) 免疫比濁測定試薬及び測定方法
US4891311A (en) Stabilized enzyme conjugate composition
US4081525A (en) Radioimmunoassay of plasma steroids
US3938954A (en) Determination of calcium
US5342788A (en) Method and standard solution for the determination of thyroxine (T4) or triiodothyronine (T3)
US6387711B1 (en) Liquid intact parathyroid hormone (PTH) standards
US4267272A (en) Prostatic acid phosphatase immuno assay
US4030885A (en) Bilirubin determination
CN114324898B (zh) 用于肝素结合蛋白hbp检测的结合垫处理液
JP3298812B2 (ja) 尿中トリプシンインヒビターの測定方法
DE19543569A1 (de) Verwendung des Lectins Sambucus nigra zur Quantifizierung der endständigen Sialinsäurereste des Human-Transferrin-Moleküls mittels einer vollimmunoenzymatischen Methode (EIA)
CN113252909A (zh) 一种基于量子点免疫荧光检测试剂盒及其制备方法
US4724203A (en) Caproylamidobiotinylated peroxidase
CN120847391A (zh) 一种样本稀释液及其应用、试剂盒
JPH08211056A (ja) 免疫反応媒体組成物、酵素標識抗体組成物、該組成物の安定化方法、該組成物を用いる免疫学的測定法及び免疫学的測定法用キット
GB2269231A (en) "A colour stable chromogen composition"

Legal Events

Date Code Title Description
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

G160 Decision to publish patent application
PG1605 Publication of application before grant of patent

St.27 status event code: A-2-2-Q10-Q13-nap-PG1605

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U11-oth-PR1002

Fee payment year number: 1

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

FPAY Annual fee payment

Payment date: 19940411

Year of fee payment: 5

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 19950502

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 19950502